159 related articles for article (PubMed ID: 20531984)
1. CCN5, a secreted protein, localizes to the nucleus.
Wiesman KC; Wei L; Baughman C; Russo J; Gray MR; Castellot JJ
J Cell Commun Signal; 2010 Jun; 4(2):91-8. PubMed ID: 20531984
[TBL] [Abstract][Full Text] [Related]
2. CCN5 Expression in mammals. II. Adult rodent tissues.
Gray MR; Malmquist JA; Sullivan M; Blea M; Castellot JJ
J Cell Commun Signal; 2007 Sep; 1(2):145-58. PubMed ID: 18481204
[TBL] [Abstract][Full Text] [Related]
3. CCN5 is a growth arrest-specific gene that regulates smooth muscle cell proliferation and motility.
Lake AC; Bialik A; Walsh K; Castellot JJ
Am J Pathol; 2003 Jan; 162(1):219-31. PubMed ID: 12507905
[TBL] [Abstract][Full Text] [Related]
4. Domain-and species-specific monoclonal antibodies recognize the Von Willebrand Factor-C domain of CCN5.
Wei L; McKeon F; Russo JW; Lemire J; Castellot J
J Cell Commun Signal; 2009 Mar; 3(1):65-77. PubMed ID: 19401828
[TBL] [Abstract][Full Text] [Related]
5. The TSP-1 domain of the matricellular protein CCN5 is essential for its nuclear localization and anti-fibrotic function.
Song MH; Jo Y; Kim YK; Kook H; Jeong D; Park WJ
PLoS One; 2022; 17(4):e0267629. PubMed ID: 35476850
[TBL] [Abstract][Full Text] [Related]
6. CCN5 expression in mammals : I. Embryonic and fetal tissues of mouse and human.
Jones JA; Gray MR; Oliveira BE; Koch M; Castellot JJ
J Cell Commun Signal; 2007 Sep; 1(2):127-43. PubMed ID: 18481203
[TBL] [Abstract][Full Text] [Related]
7. CCN5/WISP-2 promotes growth arrest of triple-negative breast cancer cells through accumulation and trafficking of p27(Kip1) via Skp2 and FOXO3a regulation.
Haque I; Banerjee S; De A; Maity G; Sarkar S; Majumdar M; Jha SS; McGragor D; Banerjee SK
Oncogene; 2015 Jun; 34(24):3152-63. PubMed ID: 25132260
[TBL] [Abstract][Full Text] [Related]
8. The carboxyl-terminal TSP1-homology domain is the biologically active effector peptide of matricellular protein CCN5 that counteracts profibrotic CCN2.
Zolfaghari S; Kaasbøll OJ; Monsen VT; Sredic B; Hagelin EMV; Attramadal H
J Biol Chem; 2023 Jan; 299(1):102803. PubMed ID: 36529291
[TBL] [Abstract][Full Text] [Related]
9. Role of CCN5 (WNT1 inducible signaling pathway protein 2) in pancreatic islets.
Liu JL; Kaddour N; Chowdhury S; Li Q; Gao ZH
J Diabetes; 2017 May; 9(5):462-474. PubMed ID: 27863006
[TBL] [Abstract][Full Text] [Related]
10. WISP-2/CCN5 is involved as a novel signaling intermediate in phorbol ester-protein kinase Calpha-mediated breast tumor cell proliferation.
Sengupta K; Banerjee S; Dhar K; Saxena NK; Mehta S; Campbell DR; Banerjee SK
Biochemistry; 2006 Sep; 45(35):10698-709. PubMed ID: 16939222
[TBL] [Abstract][Full Text] [Related]
11. Degradomic and yeast 2-hybrid inactive catalytic domain substrate trapping identifies new membrane-type 1 matrix metalloproteinase (MMP14) substrates: CCN3 (Nov) and CCN5 (WISP2).
Butler GS; Connor AR; Sounni NE; Eckhard U; Morrison CJ; Noël A; Overall CM
Matrix Biol; 2017 May; 59():23-38. PubMed ID: 27471094
[TBL] [Abstract][Full Text] [Related]
12. Role of WISP-2/CCN5 in the maintenance of a differentiated and noninvasive phenotype in human breast cancer cells.
Fritah A; Saucier C; De Wever O; Bracke M; Bièche I; Lidereau R; Gespach C; Drouot S; Redeuilh G; Sabbah M
Mol Cell Biol; 2008 Feb; 28(3):1114-23. PubMed ID: 18070926
[TBL] [Abstract][Full Text] [Related]
13. Molecular cloning and characterization of the human WISP-2/CCN5 gene promoter reveal its upregulation by oestrogens.
Fritah A; Redeuilh G; Sabbah M
J Endocrinol; 2006 Dec; 191(3):613-24. PubMed ID: 17170219
[TBL] [Abstract][Full Text] [Related]
14. The matricellular protein CCN5 regulates podosome function via interaction with integrin αvβ 3.
Myers RB; Wei L; Castellot JJ
J Cell Commun Signal; 2014 Jun; 8(2):135-46. PubMed ID: 24488697
[TBL] [Abstract][Full Text] [Related]
15. Gain of oncogenic function of p53 mutants induces invasive phenotypes in human breast cancer cells by silencing CCN5/WISP-2.
Dhar G; Banerjee S; Dhar K; Tawfik O; Mayo MS; Vanveldhuizen PJ; Banerjee SK
Cancer Res; 2008 Jun; 68(12):4580-7. PubMed ID: 18559502
[TBL] [Abstract][Full Text] [Related]
16. Expression and biological function of the cellular communication network factor 5 (CCN5) in primary liver cells.
Borkham-Kamphorst E; Meurer SK; Weiskirchen R
J Cell Commun Signal; 2023 Jun; 17(2):307-320. PubMed ID: 37166689
[TBL] [Abstract][Full Text] [Related]
17. CCN5: biology and pathophysiology.
Russo JW; Castellot JJ
J Cell Commun Signal; 2010 Oct; 4(3):119-30. PubMed ID: 21063502
[TBL] [Abstract][Full Text] [Related]
18. CCN5 overexpression inhibits profibrotic phenotypes via the PI3K/Akt signaling pathway in lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis and in an in vivo model of lung fibrosis.
Zhang L; Li Y; Liang C; Yang W
Int J Mol Med; 2014 Feb; 33(2):478-86. PubMed ID: 24276150
[TBL] [Abstract][Full Text] [Related]
19. Characterization of bone morphology in CCN5/WISP5 knockout mice.
Jiang J; Zhao G; Lyons KM
J Cell Commun Signal; 2018 Mar; 12(1):265-270. PubMed ID: 29396648
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor-1 (IGF-1) induces WISP-2/CCN5 via multiple molecular cross-talks and is essential for mitogenic switch by IGF-1 axis in estrogen receptor-positive breast tumor cells.
Dhar K; Banerjee S; Dhar G; Sengupta K; Banerjee SK
Cancer Res; 2007 Feb; 67(4):1520-6. PubMed ID: 17308090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
